Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Colonic Neoplasms 1Breast Neoplasms 1Bile Duct Neoplasms 1

Interventions

Gastrectomy 13Observation 12Gastroscopy 11Drug Therapy 9Surveys and Questionnaires 8Surgical Procedures, Operative 8Endoscopic Mucosal Resection 8Paclitaxel 6Immune Checkpoint Inhibitors 6Blood Specimen Collection 6Tomography, X-Ray Computed 5Oxaliplatin 5Trastuzumab 4Ramucirumab 4Irinotecan 4Immunotherapy 4Hyperthermic Intraperitoneal Chemotherapy 4Cisplatin 4Biopsy 4tislelizumab 3S 1 (combination) 3Robotic Surgical Procedures 3Radiotherapy 3Positron Emission Tomography Computed Tomography 3Nivolumab 3Neoadjuvant Therapy 3Laparoscopy 3Interviews as Topic 3Capecitabine 3taxane 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Stomach Neoplasms × Dihydrouracil Dehydrogenase (NADP) × Clear all
NCT05266300 2022-11-01

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

University of Southern Denmark

Completed
722 enrolled
BreastGastrointestinal

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡